Protein Delivery Using Cys2–His2 Zinc-Finger Domains
The development of new methods for delivering proteins into cells is a central challenge for
advancing both basic research and therapeutic applications. We previously reported that …
advancing both basic research and therapeutic applications. We previously reported that …
Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV–TAT peptide …
M Fretz, J Jin, R Conibere, NA Penning… - Journal of Controlled …, 2006 - Elsevier
Protein transduction domains such as those derived from the HIV protein TAT have great
potential as vectors for delivery of therapeutic entities such as genes and proteins into cells …
potential as vectors for delivery of therapeutic entities such as genes and proteins into cells …
Delivery of negatively charged proteins using cationic lipids
2019-02-22 Assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
Guanidine‐containing molecular transporters: sorbitol‐based transporters show high intracellular selectivity toward mitochondria
KK Maiti, WS Lee, T Takeuchi, C Watkins… - Angewandte …, 2007 - Wiley Online Library
The therapeutic efficacy of a drug depends on its ability to reach the desired target tissues,
cells, and even intracellular organelles. However, these biological structures are highly …
cells, and even intracellular organelles. However, these biological structures are highly …
[HTML][HTML] A naturally occurring polymorphism in the HIV-1 tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation
AP Ruiz, DO Ajasin, S Ramasamy, V DesMarais… - Scientific reports, 2019 - nature.com
HIV-1 Tat protein contributes to HIV-neuropathogenesis in several ways including its ability
to be taken up by uninfected bystander CNS cells and to activate inflammatory host genes …
to be taken up by uninfected bystander CNS cells and to activate inflammatory host genes …
Endosomolytic nano-polyplex platform technology for cytosolic peptide delivery to inhibit pathological vasoconstriction
BC Evans, KM Hocking, KV Kilchrist, ES Wise… - ACS …, 2015 - ACS Publications
A platform technology has been developed and tested for delivery of intracellular-acting
peptides through electrostatically complexed nanoparticles, or nano-polyplexes, formulated …
peptides through electrostatically complexed nanoparticles, or nano-polyplexes, formulated …
Harnessing the power of cell‐penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents
SR MacEwan, A Chilkoti - Wiley Interdisciplinary Reviews …, 2013 - Wiley Online Library
Targeted delivery of cancer therapeutics and imaging agents aims to enhance the
accumulation of these molecules in a solid tumor while avoiding uptake in healthy tissues …
accumulation of these molecules in a solid tumor while avoiding uptake in healthy tissues …
[HTML][HTML] Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates
The increased need for macromolecular therapeutics, such as peptides, proteins and
nucleotides, to reach intracellular targets necessitates more effective delivery vectors and a …
nucleotides, to reach intracellular targets necessitates more effective delivery vectors and a …
Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells
DX Ma, NQ Shi, XR Qi - International journal of pharmaceutics, 2011 - Elsevier
The application of cell-penetrating peptides (CPPs) for delivering various cargo molecules
with biological functions into cells has gained much attention in recent years. However, the …
with biological functions into cells has gained much attention in recent years. However, the …
Levofloxacin and indolicidin for combination antimicrobial therapy
K Abdul Ghaffar, WM Hussein, ZG Khalil… - Current Drug …, 2015 - ingentaconnect.com
Despite the increasing need for antibiotics to fight infectious diseases, fewer new antibiotics
are available on the market. Unfortunately, developing a new class of antibiotics is …
are available on the market. Unfortunately, developing a new class of antibiotics is …